Cary Street Partners’s Honeywell HON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.61M Sell
29,506
-21,842
-43% -$4.87M 0.14% 158
2026
Q1
$11.6M Buy
51,348
+738
+1% +$169K 0.29% 84
2025
Q4
$9.87M Sell
50,610
-406
-0.8% -$79.4K 0.24% 99
2025
Q3
$10.1M Buy
51,016
+1,089
+2% +$228K 0.26% 91
2025
Q2
$11M Buy
49,927
+1,643
+3% +$333K 0.31% 82
2025
Q1
$9.64M Buy
48,284
+5,897
+14% +$1.19M 0.3% 81
2024
Q4
$9.02M Buy
+42,387
New +$8.84M 0.29% 89

Other funds holding HON

Cary Street Partners's HON Position: Q2 2026 in Review

Cary Street Partners reduced its Honeywell (HON) stake by 43% in Q2 2026, selling an estimated $4.87M and leaving 29,506 shares worth $6.61M. The position accounts for 0.14% of the portfolio, ranked #158.

Cary Street Partners first reported a position in HON in Q4 2024 and has held it in 7 quarters since. The position peaked at $11.6M in Q1 2026. 2,152 funds tracked by Wall St. Rank hold HON as of Q2 2026.

  • Cary Street Partners held 29,506 shares of Honeywell worth $6.61M as of Q2 2026.
  • Cary Street Partners sold 21,842 Honeywell shares in Q2 2026, an estimated $4.87M.
  • Honeywell made up 0.14% of Cary Street Partners's portfolio in Q2 2026, its #158 holding.
  • Cary Street Partners first reported a position in Honeywell in Q4 2024 and has held it in 7 quarters since.
  • Cary Street Partners's Honeywell position peaked at $11.6M in Q1 2026.
  • 2,152 funds tracked by Wall St. Rank held Honeywell as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.